October 30, 2026Stocks·Bullish·legal
Missouri jury rejects three women's Roundup cancer claims against Bayer's Monsanto
A Missouri jury ruled in favor of Bayer's Monsanto business in a trial over claims that its Roundup weedkiller caused cancer, rejecting allegations of design defect, fraud and negligence brought by three plaintiffs. It was Bayer's first US trial victory since a favorable Supreme Court ruling in June; Bayer said it will continue defending its glyphosate-based products while pursuing a $7.25 billion settlement strategy.
Detected & updated continuously · Source: Nebula
Story subjects
Bayer AGSt. Louis